期刊文献+

游离与总前列腺特异性抗原比值测定对前列腺癌的诊断价值 被引量:2

下载PDF
导出
作者 赵春辉
出处 《江西医学检验》 2004年第3期274-274,220,共2页 Jiangxi Journal of Medical Laboratory Sciences
  • 相关文献

参考文献8

  • 1邵远.游离前列腺特异性抗原与总前列腺特异性抗原比值在前列腺癌诊断中的意义[J].中华肿瘤杂志,1999,21(5):338-338.
  • 2Oesterling JE, Jacobsen S J, Klee GG, et al. Free complexed and total serum prostate specific antigen:the estabishment of appropriate reference ranges for their concertrations and ratios[J]. J Urol ,1995,154:1090~1095.
  • 3Oesterling J.prostate specific antigen :a cirtical assessment of the most useful tumor make for adenocarcinoma of the prostat [J]. J Urol, 145:907~923.
  • 4李笑弓,周志耀.前列腺癌诊断与治疗的进展[J].临床泌尿外科杂志,1998,13(10):467-470. 被引量:7
  • 5Parker SL,Tong T, Bolden S,et al. Cancer Statistics [J]. Cancer JClin, 1997,46( 1 ):5 ~27.
  • 6王健,章咏裳.不同分子形式前列腺特异性抗原早期诊断前列腺癌的研究进展[J].临床泌尿外科杂志,1999,14(11):496-499. 被引量:4
  • 7Catalona WJ, Smith DS, Wolfert R1, etal. Evaluation of free serum prostate specific antigen to improve specificity of prostate cancer screening[J].JAWA,1995,274:1214~1217.
  • 8Prestiglacoma AF,Lilja H,petlerrsson K,et al.A comparison of the free fraction of serum prostate specific antigen in men with henign and cancerous prostates:the best case scenario[J]. J Urol,1996,156:350~354.

二级参考文献18

  • 1Bos SD.An overview of current clinical experience with strontium-89 (Metastron).Prostate,1994.5(Suppl):23.
  • 2Rosen MA.Impact of PSA screening on the natural history of prostate cancer.Urology,1995.46:757.
  • 3Catalona WJ,Richie HP,Ahmann FR,et al.Comparisons of DRE and serum PSA in the early detection of prostate cancer:results of a multicenter clinical trial of 6 630 men.J Urol,1994.151:1283.
  • 4Barwer MK.The diagnosis of prostatic carcinoma.Cancer.1993.71(Suppl):899.
  • 5Apoorva RV,Joseph EO.Percent free prostate.specific antigen:Entering a new era in the detection of prostate cancer.Mayo Clin Proc,1997.72:337.
  • 6Bishoff TJ,Reyes A.Thompson IM.et al.Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate:development of a system of patient selection.Urology.1995.45:270.
  • 7Oesterling JE.Using PSA to eliminate the staging radionuclide bone scan:significant economic implications.Urol Clin North Am,1993.20:705.
  • 8Johansson JE.Expectant management of early stage prostatic cancer:Swedish experience.J Urol.1994.152:1753.
  • 9Hancock SL,Cox RS.Bagshaw MA.Prostate specific antigen after radiotherapy for prostate cancer:a re-evaluation of long term biochemical control and the kinetics of recurrence in patients treated at Stanford University,J Urol,1995.154:1421.
  • 10Shipley WU,Zietman AL,Hanks GE,et al.Treatment related sequelae following external beam radiation for prostate cancer:a review with an update in patients with stages T:and T:tumor.J Urol.1994.152:1799.

共引文献9

同被引文献5

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部